Literature DB >> 22359172

A new parental cell line for human x human hybridoma production.

S A Clark1, S E James, M Fitchett.   

Abstract

The potential of a new HAT-sensitive human lymphoblastoid cell line TK6 TG(r).P1. as a fusion partner was assessed, by comparison with the established human parental cell line UC729.6. Both of these cell lines were fused with the peripheral blood mononuclear cells of a patient with B-chronic lymphocytic leukaemia. The hybridomas generated in these fusion experiments were analysed by the fluorescence activated cell sorter and karyotyping. An anti-idiotype ELISA assay detected the presence of the patient's characteristic idiotype bearing immunoglobulin in the supernatant of a number of the hybridoma cell lines generated in both fusions.

Entities:  

Year:  1988        PMID: 22359172     DOI: 10.1007/BF00365082

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  5 in total

1.  A rapid banding technique for human chromosomes.

Authors:  M Seabright
Journal:  Lancet       Date:  1971-10-30       Impact factor: 79.321

2.  Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody.

Authors:  R A Miller; D G Maloney; R Warnke; R Levy
Journal:  N Engl J Med       Date:  1982-03-04       Impact factor: 91.245

3.  UC 729-6, a human lymphoblastoid B-cell line useful for generating antibody-secreting human-human hybridomas.

Authors:  M C Glassy; H H Handley; H Hagiwara; I Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

4.  Studies of the binding of ethidium bromide to cells before and after enzyme treatment.

Authors:  M Eisenhut; B Choné
Journal:  Histochemistry       Date:  1979-08

Review 5.  Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target.

Authors:  G T Stevenson; M J Glennie
Journal:  Cancer Surv       Date:  1985
  5 in total
  1 in total

1.  A new human fusion partner, HK-128, for making human-human hybridomas producing monoclonal IgG antibodies.

Authors:  H Kawahara; K Yamada; S Shirahata; H Murakami
Journal:  Cytotechnology       Date:  1990-09       Impact factor: 2.058

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.